Ardelyx raises 2025 IBSRELA revenue guidance to $270M-$275M as growth accelerates [Seeking Alpha]
Ardelyx, Inc. (ARDX)
Last ardelyx, inc. earnings: 3/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ardelyx.com/investor-relations
Company Research
Source: Seeking Alpha
Michael Raab, President and CEO, stated that Ardelyx delivered "another standout quarter for both IBSRELA and XPHOZAH" and emphasized a 15% year-over-year growth in product revenue, reaching $105.5 million for the third quarter. He highlighted that "IBSRELA continues to outperform Quick Insights Key growth drivers include surging IBSRELA sales (92% year-over-year growth), increased XPHOZAH revenue, and effective commercial execution resulting in market share gains and strong prescription pull-through rates. Management is investing in commercial/clinical infrastructure, focusing on patient access, reporting improved pull-through, raising guidance for IBSRELA, highlighting only 'tailwinds' for key products, and monitoring ongoing challenges like payer access and market penetration. Launching ARDX-10531 represents a next-generation pipeline milestone aimed at expanding the company's NHE3 inhibitor platform, reinvigorating its pipeline, and potentially strengthening long-term gro
Show less
Read more
Impact Snapshot
Event Time:
ARDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARDX alerts
High impacting Ardelyx, Inc. news events
Weekly update
A roundup of the hottest topics
ARDX
News
- Ardelyx (ARDX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
- Ardelyx (NASDAQ:ARDX) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating.MarketBeat
- Can Ardelyx's (ARDX) Updated IBSRELA Outlook Reveal More About Its Long-Term Growth Potential? [Yahoo! Finance]Yahoo! Finance
- BTIG Maintains a Buy on Ardelyx, Inc (ARDX) [Yahoo! Finance]Yahoo! Finance
ARDX
Earnings
- 10/30/25 - Beat
ARDX
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- ARDX's page on the SEC website